Dr. Aaron Lenhart, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1006 Main St., P.o. Bx 786, Republic, PA 15475 Phone: 724-246-9434 Fax: 724-246-9846 |
News Archive
For the first time, engineers have demonstrated an electronic device to closely monitor beating heart cells without affecting their behavior. A collaboration between the University of Tokyo, Tokyo Women's Medical University and RIKEN in Japan produced a functional sample of heart cells with a soft nanomesh sensor in direct contact with the tissue.
Hold the phone – long-term use of a cell phone may cause inner ear damage and can lead to high frequency hearing loss, according to a new study.
The drug ticagrelor has been approved since February 2016 for adults who had a myocardial infarction a year or more ago and are at a high risk of a new myocardial infarction or stroke.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Those cases generally involve nonprofit and religious organizations. Meanwhile, some employers who say their religious beliefs prevented them from complying with the contraceptive mandate say they plan to halt coverage of some methods following the Supreme Court decision, reports The Wall Street Journal, Meanwhile, attention moves to the administration as it attempts to draft new rules.
› Verified 6 days ago